Related Experiment Video
Updated: Jan 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study
Jun Watanabe1, Eiichi Kakehi2, Kazuhiko Kotani1
1Center for Community Medicine, Jichi Medical University, Shimotsuke, Japan.
Insights
Isolated low high-density lipoprotein cholesterol (HDL-C) does not predict stroke incidence. Low HDL-C combined with other dyslipidemias may increase stroke risk.
Area of Science:
- Cardiovascular epidemiology
- Neurology
- Metabolic disorders
Background:
- The role of isolated low high-density lipoprotein cholesterol (HDL-C) in stroke incidence remains unclear.
- Stroke is a leading cause of long-term disability, making stroke incidence a critical research area.
- Previous studies linked isolated low HDL-C to stroke mortality, but not incidence.
Purpose of the Study:
- To investigate whether isolated low HDL-C levels predict the incidence of first-ever stroke.
- To determine the association between non-isolated low HDL-C and stroke incidence.
Main Methods:
- A cohort study involving 11,025 community residents without prior stroke history.
- Analysis using Cox regression models to calculate Hazard Ratios (HRs) for isolated and non-isolated low HDL-C.
- Comparison of low HDL-C levels against normal HDL-C levels in relation to stroke incidence.
Main Results:
- Over a 10.7-year follow-up, 412 residents experienced their first stroke.
- The multivariable-adjusted HR for isolated low HDL-C was 1.11 (95% CI, 0.85-1.44).
- The multivariable-adjusted HR for non-isolated low HDL-C was 1.35 (95% CI, 1.01-1.81).
Conclusions:
- Isolated low HDL-C levels are not a significant predictor of stroke incidence.
- Low HDL-C in conjunction with other dyslipidemias may contribute to stroke incidence.
- Findings suggest that the presence of other lipid abnormalities is crucial for low HDL-C to impact stroke risk.
Background:
The cardiovascular relevance of isolated low levels of high-density lipoprotein cholesterol (HDL-C) is yet to be determined. Stroke often leads to long-term disability, and thus, not only stroke mortality but also stroke incidence is a topic of research. Although isolated low HDL-C level has been found to be a predictor for stroke mortality previously, whether it can predict stroke incidence is unknown.
Methods:
In the Jichi Medical School cohort study, 11 025 community-living residents without a history of stroke were examined. Hazard ratios (HRs) for isolated and non-isolated low HDL-C levels were calculated relative to those for normal HDL-C levels in stroke patients using Cox's regression models.
Results:
During the mean follow-up period of 10.7 years, 412 residents had their first-ever stroke. The multivariable-adjusted HRs for the levels of isolated and non-isolated low HDL-C were 1.11 (95% confidence interval, 0.85-1.44) and 1.35 (1.01-1.81), respectively, when compared to that for normal HDL-C.
Conclusion:
Low HDL-C levels with other dyslipidemias may contribute to the incidence of stroke, not isolated low HDL-C.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
